Thomas G. Trautmann, M.D.

Thomas G. Trautmann, M.D.
Place of Birth

Cincinnati, Ohio


Marital Status

Married, two children


Education  
9/1/71 - 6/30/75

Xavier University
Cincinnati, Ohio
B.S. Natural Sciences

9/1/75 - 6/30/79

University of Cincinnati College of Medicine
Cincinnati, Ohio
Medical Degree


Postdoctoral Training  
7/1/79 - 6/30/80
Internship
Georgetown University Medical Service
D.C. General Hospital, Washington, D.C.
(Internal Medicine)
7/1/80 - 6/30/82
Residency

University of Michigan Medical Center
Ann Arbor, Michigan
(Internal Medicine)

7/1/83 - 6/30/86
Fellowship

Yale University Medical School
New Haven, Connecticut
(Medical Oncology)

7/1/95 - 6/15/98
Residency

Bowman Gray School of Medicine
Winston-Salem, NC
(Radiation Oncology)


Private Practice  
7/1/86 - 6/30/95

Medical Oncologist and Internist
Charlotte Medical Clinic
Charlotte, NC1986-1995

6/15/98-Present

Radiation Oncologist
Southeast Radiation Oncology Group, P.A.
Charlotte, NC

Other:
9/1/82 - 6/15/83

Volunteer, Physician
Nong Samet Refugee Camp
Cambodia (Kampuchea)
American Refugee Committee


Professional Licensure  
5/3/86-Present

North Carolina
South Carolina


Board Certification  
9/15/82

American Board of Internal Medicine

11/19/85

Specialty Boards in Medical Oncology

5/20/99

American Board of Radiology (Radiation Oncology)


Honors/Awards

Valedictorian of Xavier University, graduating class of 1975

Recipient, Thomas Rardin Scholarship, Ohio Academy of Family Physicians, 1979

Best Medical Paper, Michigan Resident's ACP Meeting, 1982

Recipient of Visiting Oncologist Award (education/travel grant) from the American Radium Society (ARS), 1997

Recipient of Howard H Wong Fellowship in Radiation Oncology, from the American College of Radiation Oncology (ACRO), 1997

Recipient of William T. Moss Travel Award, from American College of Radiology (ACR), 1997


Grants

Gaston County Cancer Society Research Grant: "Low-grade gliomas: the impact of ploidy and proliferation on treatment recommendations and prognosis" 1997


Professional Organizations and Committees

Oncology Committee, Presbyterian Hospital 1986-1994

Cancer Committee, Carolinas Medical Center, 1986-1994

Principal Investigator for Oncology Protocols, Carolinas Medical Center 1988-1995

Chairman, Blood Usage Committee, Presbyterian Hospital, 1988-1990

Chairman, Oncology Quality Assurance Committee, Carolinas Medical Center, 1988-1992

Medical Director, Hospice at Charlotte, 1989-1990; 1999-2002

Board of Directors, CanCare (cancer support group), 1989-1995

Board of Directors, American Cancer Society, 1993-1995

Clinical Associate Professor of Medicine, UNC-Chapel Hill, 1986-1995

Division Head (Oncology), Dept. of Internal Medicine, Carolinas Medical Center, 1989-1995

Executive Committee, Carolinas Medical Center, 1993-1995

Isotope and Radiation Safety Committee, Carolinas Medical Center, 1990-1995

Pharmacy and Therapeutics Committee, Carolinas Medical Center, 1992-1994

Laboratory Director, Charlotte Medical Clinic, 1990-1995

Principle Investigator, Study of Implantable BCNU Wafers in the Treatment of Recurrent or Newly Diagnosed Brain Tumors (with Scios-Nova Co.), 1990-1993

Founding Member of Multi-Disciplinary Breast Cancer Clinic, Carolinas Medical Center, 1991-1995

Founding Member of Multi-Disciplinary Lung Cancer Clinic, Carolinas Medical Center, 1992-1995

Founding Member of Multi-Disciplinary Brain Tumor Clinic, Carolinas Medical Center, 1993-1995

Founding Member of Multi-Disciplinary Melanoma Clinic, Carolinas Medical Center, 1994-1995

Volunteer, Charlotte Homeless Shelter Medical Clinic, 1987-1995

Executive Committee of the Association of Residents in Radiation Oncology (ARRO), 1996-1998

American College of Radiology (ACR) Committee on Government and Public Relations, 1996-1998

Education Committee, Radiation Oncology, Dept. Bowman Gray School of Medicine, 1996-1998

ARRO representative to the American College of Radiology (ACR), 1997-1998

ARRO representative to Council of Affiliated Regional Radiation Oncology Societies (CARROS), 1997-1998

ASTRO Human Resources Committee, 1997-1998

ASTRO Allied Health Manpower Committee, 1997-1998

Cancer Committee, Union Regional Medical Center, 2002-Present

Radiation Safety Committee, Carolinas Medical Center-Union, 2002- Present

Director, Tumor Board Conference, Carolinas Medical Center-Union, 2002-Present

Secretary, Executive Committee, Carolinas Medical Center-Union, 2006-Present


Professional Organizations

American Society of Clinical Oncology (ASCO)
American Society of Therapeutic Radiology Oncology (ASTRO)
American College of Radiation Oncology (ACRO)
North Carolina Medical Society
Mecklenburg County Medical Society


Publications

Trautmann, T, and Kirkwood J. Adjuvant Therapy Melanoma. Hosp Therapy, 1985; 10(4):46-55

Trautmann T, and Kirkwood J. Advanced Melanoma: Conventional Therapies Hosp Therapy, 1985; 10(5):64-72

Trautmann T, and Kirkwood J. Advanced Melanoma: New Approaches. Hosp Therapy, 1985; 10(6):38-49

Trautmann T, Chang P, Reddy A, et al. 5'-Pyrimidine Nucleoside Derivatives as Potential Probes in Normal and Defective Nucleoside Transport. Proc AACR, 1985; 1045

Trautmann T, Kirkwood J, Ernstoff M, et al. Phase I-II Trial of Recombinant Interferon Gamma by Two or 24 Hour Infusion in 30 Melanoma Patients. Proc ASCO, 1985; C-905

Trautmann T, Faderan M, Holdrige C, et al Affinity Chromatography in the Isolation of the Nucleoside Transporter. Proc AACR, 1986:94

Ernstoff M, Trautmann T, Davis C, et al A Randomized Phase I/II Study of Continuous Versus Intermittent Intravenous Interferon Gamma in Patients with Metastatic Melanoma. J Clin Oncol, 1987; 5:1804-1810

Kirkwood J, Ernstoff M, Trautmann T, et al In vivo Biological Response to Recombinant Interferon-Gamma During a Phase I Dose-Response Trial in Patients with Metastatic Melanoma. J Clin Oncol, 1990; 8(6):1070-1082

Trautmann T, and Shaw E. Low-Grade Glioma - Is There a Role for Radiation Therapy? Ann Acad Med Singapore, 1996; 25:392-396

Trautmann TG, and Zuger JH. Positron Emission Tomography for Pretreatment Staging and Post treatment Evaluation in Cancer of the Anal Canal. Mol Imaging Biol, 2005; 309-313.